AstraZeneca turns to Oracle for AI-driven clinical trial enrolment

Oct 26, 2026 · Issue 13 · 2 sources, 2 articles

AstraZeneca has chosen Oracle for AI-based clinical trial patient recruitment. The news appeared on 26 October.

Who is affected and how

pharmaceuticals

Recruitment time is one of the main bottlenecks in trials, so this solution may also affect site selection and scheduling.

Sources

• AstraZeneca Taps Oracle for AI Clinical Trial Enrolmentzenopa · Oct 26, 2026
• AstraZeneca Taps Oracle for AI Clinical Trial Enrolment - Pharmaceutical Industry News - Zenopa UKzenopa.com · Oct 26, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.